2017-12104. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Products  

  • Start Preamble Start Printed Page 26937

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by July 12, 2017.

    ADDRESSES:

    To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910-0025. Also include the FDA docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    JonnaLynn Capezzuto, Office of Operations, Food and Drug Administration, Three White Flint North 10A63, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-3794, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Electronic Products OMB Control Number 0910-0025—Reinstatement

    Under sections 532 through 542 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360ii through 360ss), FDA has the responsibility to protect the public from unnecessary exposure of radiation from electronic products. The regulations issued under these authorities are listed in Title 21 of the Code of Federal Regulations, chapter I, subchapter J, parts 1000 through 1050 (21 CFR parts 1000 through 1050).

    Section 532 of the FD&C Act directs the Secretary of Health and Human Services (the Secretary), to establish and carry out an electronic product radiation control program, including the development, issuance, and administration of performance standards to control the emission of electronic product radiation from electronic products. The program is designed to protect the public health and safety from electronic radiation, and the FD&C Act authorizes the Secretary to procure (by negotiation or otherwise) electronic products for research and testing purposes and to sell or otherwise dispose of such products. Section 534(g) of the FD&C Act directs the Secretary to review and evaluate industry testing programs on a continuing basis; and section 535(e) and (f) of the FD&C Act directs the Secretary to immediately notify manufacturers of, and ensure correction of, radiation defects or noncompliance with performance standards. Section 537(b) of the FD&C Act contains the authority to require manufacturers of electronic products to establish and maintain records (including testing records), make reports, and provide information to determine whether the manufacturer has acted in compliance.

    The regulations under parts 1002 through 1010 specify reports to be provided by manufacturers and distributors to FDA and records to be maintained in the event of an investigation of a safety concern or a product recall. FDA conducts laboratory compliance testing of products covered by regulations for product standards in parts 1020, 1030, 1040, and 1050.

    FDA details product-specific performance standards that specify information to be supplied with the product or require specific reports. The information collections are either specifically called for in the FD&C Act or were developed to aid the Agency in performing its obligations under the FD&C Act. The data reported to FDA and the records maintained are used by FDA and the industry to make decisions and take actions that protect the public from radiation hazards presented by electronic products. This information refers to the identification of, location of, operational characteristics of, quality assurance programs for, and problem identification and correction of electronic products. The data provided to users and others are intended to encourage actions to reduce or eliminate radiation exposures.

    FDA uses the following forms to aid respondents in the submission of information for this information collection:

    Form FDA 2579 “Report of Assembly of a Diagnostic X-Ray System”

    Form FDA 2767 “Notice of Availability of Sample Electronic Product”

    Form FDA 2877 “Declaration for Imported Electronic Products Subject to Radiation Control Standards”

    Form FDA 3649 “Accidental Radiation Occurrence (ARO)”

    Form FDA 3626 “A Guide for the Submission of Initial Reports on Diagnostic X-Ray Systems and Their Major Components”

    Form FDA 3627 “Diagnostic X-Ray CT Products Radiation Safety Report”

    Form FDA 3628 “General Annual Report (Includes Medical, Analytical, and Industrial X-Ray Products Annual Report)”

    Form FDA 3629 “Abbreviated Report”

    Form FDA 3630 “Guide for Preparing Product Reports on Sunlamps and Sunlamp Products”

    Form FDA 3631 “Guide for Preparing Annual Reports on Radiation Safety Testing of Sunlamp Products”

    Form FDA 3632 “Guide for Preparing Product Reports on Lasers and Products Containing Lasers”

    Form FDA 3633 “General Variance Request”

    Form FDA 3634 “Television Products Annual Report”

    Form FDA 3635 “Laser Light Show Notification”

    Form FDA 3636 “Guide for Preparing Annual Reports on Radiation Safety Testing of Laser and Laser Light Show Products”

    Form FDA 3637 “Laser Original Equipment Manufacturer (OEM) Report”

    Form FDA 3638 “Guide for Filing Annual Reports for X-Ray Components and Systems”

    Form FDA 3639 “Guidance for the Submission of Cabinet X-Ray System Reports Pursuant to 21 CFR 1020.40

    Form FDA 3640 “Reporting Guide for Laser Light Shows and Displays”

    Form FDA 3147 “Application for a Variance From 21 CFR 1040.11(c) for a Laser Light Show, Display, or Device”

    Form FDA 3641 “Cabinet X-Ray Annual Report”

    Form FDA 3642 “General Correspondence”

    Form FDA 3643 “Microwave Oven Products Annual Report”

    Form FDA 3644 “Guide for Preparing Product Reports for Ultrasonic Therapy Products”

    Form FDA 3645 “Guide for Preparing Annual Reports for Ultrasonic Therapy Products”

    Form FDA 3646 “Mercury Vapor Lamp Products Radiation Safety Report”

    Form FDA 3647 “Guide for Preparing Annual Reports on Radiation Safety Testing of Mercury Vapor Lamps”

    Form FDA 3659 “Reporting and Compliance Guide for Television Products”

    Form FDA 3660 “Guidance for Preparing Reports on Radiation Safety of Microwave Ovens”

    Form FDA 3661 “A Guide for the Submission of an Abbreviated Report on X-Ray Tables, Cradles, Film Changers or Cassette Holders Intended for Diagnostic Use”Start Printed Page 26938

    Form FDA 3662 “A Guide for the Submission of an Abbreviated Radiation Safety Report on Cephalometric Devices Intended for Diagnostic Use”

    Form FDA 3663 “Abbreviated Reports on Radiation Safety for Microwave Products (Other than Microwave Ovens)”

    Form FDA 3801 “Guide for Preparing Initial Reports and Model Change Reports on Medical Ultraviolet Lamps and Products Containing Such Lamps”

    The respondents to this information collection are electronic product and x-ray manufacturers, importers, and assemblers. The burden estimates were derived by consultation with FDA and industry personnel, and are based on data collected from industry, including recent product report submissions. An evaluation of the type and scope of information requested was also used to derive some time estimates.

    In the Federal Register of November 10, 2016 (81 FR 79030), FDA published a 60-day notice requesting public comment on the proposed collection of information.

    FDA received five comments relating to potential changes to the process by which the FDA distributes and collects Form FDA 2579, “Report of Assembly of a Diagnostic X-Ray System.” While these comments were not responsive to the four information collection-related topics on which we requested comment, FDA would like to provide assurance that these comments have been noted and are being considered as part of FDA's efforts to review the process by which Form FDA 2579 is distributed and collected.

    FDA estimates the burden of this collection of information as follows:

    Table 1—Estimated Annual Reporting Burden 1 2

    Activity/21 CFR sectionFDA form No.Number of respondentsNumber of responses per respondentTotal annual responsesAverage burden per responseTotal hours
    Product reports—1002.10(a) through (k)3626—Diagnostic x-ray; 3627—CT x-ray; 3639—Cabinet x-ray; 3632—Laser; 3640—Laser light show; 3630—Sunlamp; 3646—Mercury vapor lamp; 3644—Ultrasonic therapy; 3659—TV; 3660—Microwave oven; 3801—UV lamps1,4002.23,0802473,920
    Product safety or testing changes—1002.11(a) and (b)4802.51,200.5 (30 minutes)600
    Abbreviated reports—1002.123629—General abbreviated report; 3661—X-ray tables, etc.; 3662—Cephalometric device; 3663—Microwave products (non-oven)601.81085540
    Annual reports—1002.13(a) and (b)3628—General; 3634—TV; 3638—Diagnostic x-ray; 3641—Cabinet x-ray; 3643—Microwave oven; 3636—Laser; 3631—Sunlamp; 3647—Mercury vapor lamp; 3645—Ultrasonic therapy1,6601.32,1581838,844
    Quarterly updates for new models—1002.13(c)1201.4168.5 (30 minutes)84
    Accidental radiation occurrence reports—1002.203649—ARO306.72012402
    Exemption requests—1002.50(a) and 1002.513642—General correspondence41.3515
    Product and sample information—1005.102767—Sample product515.1 (6 minutes)1
    Identification information and compliance status—1005.252877—Imports declaration12,6202.531,550.2 (12 minutes)6,310
    Alternate means of certification—1010.2(d)122510
    Variance—1010.4(b)3633—General variance request; 3147—Laser show variance request; 3635—Laser show notification3501.13851.2462
    Exemption from performance standards—1010.5(c) and (d)1112222
    Alternate test procedures—1010.131111010
    Report of assembly of diagnostic x-ray components—1020.30(d), (d)(1), and (2)2579—Assembler report1,2303441,820.30 (18 minutes)12,546
    Microwave oven exemption from warning labels—1030.10(c)(6)(iv)11111
    Laser products registration—1040.10(a)(3)(i)3637—OEM report702.92033609
    Total134,366
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    2 Numbers have been rounded.

    Table 2—Estimated Annual Recordkeeping Burden 1 2

    Activity/21 CFR sectionNumber of recordkeepersNumber of records per recordkeeperTotal annual recordsAverage burden per recordkeepingTotal hours
    Manufacturers records—1002.30 and 1002.31(a)1,6501,6502,722,500.12 (7 minutes)326,700
    Dealer/distributor records—1002.40 and 1002.413,11050155,500.05 (3 minutes)7,775
    Information on diagnostic x-ray systems—1020.30(g)50150.5 (30 minutes)25
    Start Printed Page 26939
    Laser products distribution records—1040.10(a)(3)(ii)70170170
    Total334,570
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    2 Numbers have been rounded.

    Table 3—Estimated Annual Third-Party Disclosure Burden 1 2

    Activity/21 CFR sectionNumber of respondentsNumber of disclosures per respondentTotal annual disclosuresAverage burden per disclosureTotal hours
    Technical and safety information for users—1002.31111212
    Dealer/distributor records—1002.40 and 1002.4130390190
    Television receiver critical component warning—1020.10(c)(4)11111
    Cold-cathode tubes—1020.20(c)(4)11111
    Information on diagnostic x-ray systems—1020.30(g)61655330
    Statement of maximum line current of x-ray systems—1020.30(g)(2)6161060
    Diagnostic x-ray system safety and technical information—1020.30(h)(1) through (4)6162001,200
    Fluoroscopic x-ray system safety and technical information—1020.30(h)(5) and (6) and 1020.32(a)(1), (g), and (j)(4)51525125
    CT equipment—1020.33(c), (d), (g)(4), and (j)515150750
    Cabinet x-ray systems information—1020.40(c)(9)(i) and (ii)61640240
    Microwave oven radiation safety instructions—1030.10(c)(4)1112020
    Microwave oven safety information and instructions—1030.10(c)(5)(i) through (iv)1112020
    Microwave oven warning labels—1030.10(c)(6)(iii)11111
    Laser products information—1040.10(h)(1)(i) through (vi)3132060
    Laser product service information—1040.10(h)(2)(i) and (ii)3132060
    Medical laser product instructions—1040.11(a)(2)2121020
    Sunlamp products instructions—1040.201111010
    Mercury vapor lamp labeling—1040.30(c)(1)(ii)11111
    Mercury vapor lamp permanently affixed labels—1040.30(c)(2)11111
    Ultrasonic therapy products—1050.10(d)(1) through (4), (f)(1), and (f)(2)(iii)1115656
    Total3,058
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    2 Numbers have been rounded.
    Start Signature

    Dated: May 25, 2017.

    Anna K. Abram,

    Deputy Commissioner for Policy, Planning, Legislation, and Analysis.

    End Signature End Supplemental Information

    [FR Doc. 2017-12104 Filed 6-9-17; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
06/12/2017
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2017-12104
Dates:
Fax written comments on the collection of information by July 12, 2017.
Pages:
26937-26939 (3 pages)
Docket Numbers:
Docket No. FDA-2013-N-0618
PDF File:
2017-12104.pdf